Fudan University-affiliated Zhongshan Hospital continues to lead in minimally invasive interventional treatment of heart valve disease. Technologies such as transcatheter aortic valve replacement (TAVR) are increasingly mature, bringing new treatment hope to elderly patients who cannot tolerate traditional open-heart surgery.
Technical advantages
The cardiology team at Zhongshan Hospital has accumulated rich experience in valve intervention, with a complete system of preoperative evaluation, intraoperative operation and postoperative management. TAVR completes valve replacement through femoral artery puncture, with less trauma and faster recovery. Multiple clinical studies show its efficacy is comparable to traditional surgery.
Suitable population
Mainly suitable for patients with severe aortic stenosis, high surgical risk or inability to tolerate surgery, as well as some patients with mitral and tricuspid valve disease. The hospital's multidisciplinary team evaluates and develops individualized plans based on each patient's condition.
Treatment for international patients
Zhongshan Hospital's international medical department provides booking, multilingual interpretation and full coordination for overseas patients. Patients can first submit cardiac ultrasound and other materials through remote consultation for evaluation.
MedBridge services
MedBridge can connect international patients with Zhongshan Hospital's cardiology team, providing remote consultation, booking, interpretation accompaniment and follow-up support, making advanced cardiac treatment more accessible.